A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)

Ann Surg Oncol. 2023 Feb;30(2):683-685. doi: 10.1245/s10434-022-12762-z. Epub 2022 Nov 17.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Extremities
  • Humans
  • Radiation Oncology*
  • Radiotherapy, Adjuvant
  • Sarcoma* / drug therapy
  • Sarcoma* / radiotherapy
  • Soft Tissue Neoplasms* / drug therapy
  • Soft Tissue Neoplasms* / radiotherapy

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized